Corcept Therapeutics (CORT) Tops Q4 EPS by 1c
Tweet
Share
E-mailGet Alerts CORT Hot Sheet
Price: $117.51 +0.01%
Revenue Growth %: +56.0%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Revenue Growth %: +56.0%
Financial Fact:
Net loss and comprehensive loss: 2.59M
Today's EPS Names:
OCCI, ALZN, ASPU, More
Join SI Premium – FREE
Corcept Therapeutics (NASDAQ: CORT) reported Q4 EPS of $0.28, $0.01 better than the analyst estimate of $0.27. Revenue for the quarter came in at $135.4 million versus the consensus estimate of $130.31 million.
For earnings history and earnings-related data on Corcept Therapeutics (CORT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royal Caribbean to acquire 50% stake in Sandals Resorts for $3 billion
- Oppenheimer Starts Amneal Pharmaceuticals (AMRX) at Outperform
- Worthington Industries (WOR) Tops Q1 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
